SCA
CVS icon

Stuart Chaussee & Associates’s CVS Health CVS Stock Holding History

Stuart Chaussee & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-68
Closed -$5.05K – 135
2023
Q1 		$5.05K Sell
68
-242
-78% -$20.3K ﹤0.01% 117
2022
Q4 		$28.9K Hold
310
– – 0.01% 61
2022
Q3 		$30K Hold
310
– – 0.07% 44
2022
Q2 		$29K Hold
310
– – 0.06% 50
2022
Q1 		$31K Buy
310
+171
+123% +$18K 0.01% 63
2021
Q4 		$14K Buy
139
+71
+104% +$6.56K 0.01% 101
2021
Q3 		$6K Hold
68
– – 0.01% 124
2021
Q2 		$6K Hold
68
– – ﹤0.01% 133
2021
Q1 		$5K Buy
+68
New +$4.95K ﹤0.01% 169

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Stuart Chaussee & Associates's CVS Position: Q2 2023 in Review

Stuart Chaussee & Associates sold out of CVS Health (CVS) in Q2 2023, closing a stake of 68 shares — an estimated $5.05K sold.

Stuart Chaussee & Associates first reported a position in CVS in Q1 2021 and held it in 9 quarters. The position peaked at $31K in Q1 2022. 2,203 funds tracked by Wall St. Rank hold CVS as of Q2 2023.

  • Stuart Chaussee & Associates reported no remaining CVS Health position as of Q2 2023 after selling out during the quarter.
  • Stuart Chaussee & Associates sold 68 CVS Health shares in Q2 2023, an estimated $5.05K.
  • Stuart Chaussee & Associates first reported a position in CVS Health in Q1 2021 and held it in 9 quarters.
  • Stuart Chaussee & Associates's CVS Health position peaked at $31K in Q1 2022.
  • 2,203 funds tracked by Wall St. Rank held CVS Health as of Q2 2023.

Based on Stuart Chaussee & Associates's 13F filing for Q2 2023, filed 4 Aug 2023.